Publications and Digital Products

This updated manual contains a 12-week cognitive–behavioral anger management group treatment model. The content includes specific instructions and suggested remarks for group leaders, and exercises for group members. This model will work in a variety of clinical settings, and with diverse audiences.

This Advisory highlights how mental and substance use disorder treatment programs can better serve people with physical and cognitive disabilities and substance use disorders (SUDs) and/or serious mental illness (SMI).

This fact sheet provides information and resources related to the specific bullying prevention needs for American Indian and Alaska Native communities. It highlights effective school-based anti-bullying prevention strategies.

This report gives an overview of suicide prevention strategies used in Alaska. It provides background information on the suicide epidemic within the state, and explores the effectiveness of recent suicide prevention efforts. It also highlights data on suicide rates among American Indians and Alaskan Natives.

Gives patients information on buprenorphine and medication-assisted treatment for opioid addiction. Describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This Korean-language brochure gives patients information on buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This guide serves as a reference for substance use treatment practitioners. It offers "how to" information divided into sections. The guide is based entirely on "Substance Abuse Treatment and Domestic Violence," number 25 in the Treatment Improvement Protocol (TIP) Series.

This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

This manual provides guidelines for the operation of opioid treatment programs. It covers patient assessment, treatment planning, and recovery care. The manual also offers guidance for medication-assisted treatment for methadone and buprenorphine, and overdose and relapse prevention.